TABLE 1.
Baseline characteristics
| Mean ± SD | Telmisartan (N = 33) | Telmisartan/rosuvastatin (N = 36) | Total (N = 69) | p‐value |
|---|---|---|---|---|
| Age (years) | 62.15(10.35) | 60.92(8.54) | 61.51(9.40) | .417 a |
| Sex (male %) | 22(66.67) | 23(63.89) | 45(65.22) | .809 b |
| Height (cm) | 162.00(8.47) | 162.53(8.76) | 162.28(8.56) | .800 c |
| Weight (kg) | 69.67(12.72) | 67.97(12.35) | 68.78(12.47) | .575 c |
| Body mass index (BMI, kg/m2) | 26.47(4.07) | 25.60(3.30) | 26.01(3.69) | .333 c |
| Brachial SBP (mmHg) | 134.37(12.50) | 135.80(14.22) | 135.28(13.76) | .648 a |
| Brachial DBP (mmHg) | 82.88(8.75) | 82.37(9.50) | 82.68(9.52) | .862 a |
| Pulse rate (BPM) | 75.49(10.74) | 76.39(11.40) | 74.47(11.13) | .736 c |
| Smoking (%) | 10(30.30) | 8(22.22) | 18(26.09) | .445 b |
| Previous antihypertensive medication (%) | 28(84.85) | 27(75.00) | 55(79.71) | .310 b |
| RAS inhibitors | 25(75.76) | 24(66.67) | 49(71.01) | .406 b |
| Calcium channel blocker | 4(12.12) | 4(11.11) | 8(11.59) | .896 b |
| Diuretics | 0(0.00) | 1(2.78) | 1(1.45) | .335 b |
| Other medication (%) | 18(54.54) | 17(47.22) | 35(50.72) | .543 b |
| Statins | 10(30.30) | 8(22.22) | 18(26.09) | .445 b |
| Antithrombotic agents | 11(33.33) | 8(22.22) | 19(27.54) | .302 b |
| Antidiabetic agents | 6(18.18) | 6(16.67) | 12(17.39) | .868 b |
Abbreviations: BPM, beats per minute; DBP, diastolic blood pressure; RAS inhibitors, renin‐angiotensin system inhibitors including angiotensin receptor blockers and angiotensin converting enzyme inhibitors; SBP, systolic blood pressure; SD, standard deviation.
a
Wilcoxon rank sum test.
b
Chi‐square test.
c
Two sample t‐test.